Comparative analysis of safety and efficacy of Alcaftadine 0.25 & #37;, Olopatadine hydrochloride 0.2 & #37; and Bepotastine besilate 1.5 & #37; in allergic conjunctivitis

Conclusion: All three topical ophthalmic medications used in the study are safe and effective in the treatment of allergic conjunctivitis. However, Bepotastine and Alcaftadine appear to outweigh Olopatadine in resolving the symptoms of allergic conjunctivitis.

Source: Indian Journal of Ophthalmology - January 18, 2021 Category: Opthalmology Authors: Shruti Ayyappanavar Sriya Sridhar Kiran Kumar CR Jayanthi Suresh Babu Gangasagara B L Sujatha Rathod B Preethi Preeti Mittal Source Type: research